Pfizer and Insurers At Odds On Lipitor Marketing

Pfizer’s new coupon card enables insured patients to purchase Lipitor for as little as $4 (vs $150). Health insurance firms, pushing generics, get stung and get pissed. Matthew Herper in Forbes:

Pfizer counters that the point of the co-pay card is to help patients, who often opt for no treatment at all when faced with a high copayment. “Only half of patients with high cholesterol are treated, and a significant barrier to treatment is cost,” says Victor Clavelli, who leads the U.S. marketing team for Lipitor. “These co-pay cards are the best way for us to address that cost. We believe when used appropriately these cards can reduce under-treatment and the number of patients who are simply not treated at all.”

Look: http://blogs.forbes.com/matthewherper/2011/03/16/how-bargain-lipitor-could-raise-health-costs/

Advertisements
This entry was posted in healthcare marketing communication. Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s